Literature DB >> 2692325

[Eczema diseases and erythemato-squamous dermatoses of aging skin--studies of the effectiveness and tolerance of Prednicarbate in various vehicles].

A Stary1, H Schulz, H Tronnier.   

Abstract

In an open multi-center study on 1,286 patients aged 60 years and more, we tested the efficacy and compatibility of prednicarbate (Dermatop) in various vehicles. The eczemas and erythematosquamous dermatoses of 857 patients (66.6%) disappeared within three weeks treatment. In 142 patients (11%), it took more than 3 weeks (62 day at the most) to achieve a complete healing. A very good or good tolerance was observed in 97.1% of the patients. Only in 1.5% the study had to be broken off because of a change for the worse. Prednicarbate, therefore, is especially suitable in the treatment of eczemas and chronic erythematosquamous dermatoses of aged skin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692325

Source DB:  PubMed          Journal:  Z Hautkr        ISSN: 0301-0481


  1 in total

1.  Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study.

Authors:  A de Tiedra; J Mercadal; R Lozano
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.